Kisho

Acrotech Biopharma Inc — Rare Disease Pipeline | Kisho | Kisho

Acrotech Biopharma Inc

Other

Specializing in rare diseases, the company has FDA-approved seven drugs and holds 11 orphan drug designations, addressing 35 conditions including various T-cell lymphomas and neurodevelopmental disorders.

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
B-cell non-Hodgkin lymphoma	Zevalin	Orphan Designation	-
Sezary syndrome	Beleodaq	Orphan Designation	-
Sotos syndrome	pralatrexate	Orphan Designation	-
T-cell non-Hodgkin lymphoma	Folotyn	Orphan Designation	-
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome	FolotynZevalin	Orphan Designation	-
acrodysostosis 2 with or without hormone resistance	pralatrexate	Orphan Designation	-
acute lymphoblastic leukemia	Marqibo	Orphan Designation	-
adult neuronal ceroid lipofuscinosis	Marqibo	Orphan Designation	-
adult pleomorphic rhabdomyosarcoma	Marqibo	Orphan Designation	-
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia	Marqibo	Orphan Designation	-
adult-onset proximal spinal muscular atrophy, autosomal dominant	Marqibo	Orphan Designation	-
carbon monoxide-induced delayed encephalopathy	Fusilev	Orphan Designation	-
cardiac anomalies - developmental delay - facial dysmorphism syndrome	BeleodaqFolotynZevalin	Orphan Designation	-
chromosome 1q21.1 deletion syndrome	EVOMELA	Orphan Designation	-
clear cell renal carcinoma	Fusilev	Orphan Designation	-
diffuse large B-cell lymphoma	pralatrexate	Orphan Designation	-
enteropathy-associated T-cell lymphoma	Beleodaq	Orphan Designation	-
follicular lymphoma	pralatrexate	Orphan Designation	-
high anorectal malformation	EVOMELA	Orphan Designation	-
high-grade B-cell lymphoma double-hit/triple-hit	EVOMELA	Orphan Designation	-
hyperopia, high	EVOMELA	Orphan Designation	-
mature T-cell and NK-cell non-Hodgkin lymphoma	Beleodaq	Orphan Designation	-
metastatic malignant neoplasm in the colon	vincristine sulfate liposomesFusilev	Orphan Designation	-
metastatic malignant neoplasm in the lymph nodes	Fusilev	Orphan Designation	-
metastatic melanoma	vincristine sulfate liposomesFusilev	Orphan Designation	-
metastatic neoplasm	vincristine sulfate liposomesFusilev	Orphan Designation	-
multisystemic smooth muscle dysfunction syndrome	FolotynZevalin	Orphan Designation	-
neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	BeleodaqFolotynZevalin	Orphan Designation	-
neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	FolotynZevalin	Orphan Designation	-
osteochondritis dissecans	pralatrexate	Orphan Designation	-
osteosarcoma	Fusilev	Orphan Designation	-
peripheral T-cell lymphoma, not otherwise specified	Beleodaq	Orphan Designation	-
primary adult heart tumor	Marqibo	Orphan Designation	-
six2-related frontonasal dysplasia	EVOMELA	Orphan Designation	-
thrombocytopenia-absent radius syndrome	EVOMELA	Orphan Designation	-

← Back to Companies